SCHEMBL1611767

SCHEMBL1611767

CC(C)(C)[Si](C)([O])C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29145 0.76
Ammonia Solution, Strong SCHEMBL28291843 0.73
Propane SCHEMBL28230936 0.67 TSHR (0.31)
SCHEMBL263794 0.64
SCHEMBL15341 0.61
SCHEMBL4389530 0.61
SCHEMBL179958 0.60
SCHEMBL28019953 0.60
SCHEMBL2144119 0.60
SCHEMBL5005529 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492390-B2 Synthesis of locked nucleic acid derivatives SANTARIS PHARMA A/S (DK) 2013-07-23 US disclosed
US-20120165514-A1 SYNTHESIS OF LOCKED NUCLEIC ACID DERIVATIVES SANTARIS PHARMA A/S (DK) 2012-06-28 US disclosed
US-8084458-B2 Synthesis of locked nucleic acid derivatives SANTARIS PHARMA A/S (DK) 2011-12-27 US disclosed
US-20110087034-A1 Organic Semiconductor Material SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2011-04-14 US disclosed
EP-2248818-A1 ORGANIC SEMICONDUCTOR MATERIAL Sumitomo Chemical Company, Limited (JP) 2010-11-10 EP disclosed
US-20100216983-A1 SYNTHESIS OF LOCKED NUCLEIC ACID DERIVATIVES SANTARIS PHARMA A/S, a Denmark corporation 2010-08-26 US disclosed
EP-0926154-B1 NOVEL LACTOSAMINE OLIGOSACCHARIDES AND PROCESS FOR THE PREPARATION THEREOF SEIKAGAKU KOGYO CO LTD (JP) 2010-01-27 EP disclosed
US-7569575-B2 Formed via intermediates which are reactive with nucleophiles SANTARIS PHARMA A/S (DK) 2009-08-04 US disclosed
EP-1501848-B1 SYNTHESIS OF LOCKED NUCLEIC ACID DERIVATIVES SANTARIS PHARMA AS (DK) 2007-08-08 EP disclosed
EP-1501848-A1 SYNTHESIS OF LOCKED NUCLEIC ACID DERIVATIVES Santaris Pharma A/S (DK) 2005-02-02 EP disclosed
US-5498819-A INHIBITORS OF PHOSPHODIESTERASE AS NEUROTROPIC AGENTS, ANTIINFLAMMATORY AGENTS, MUSCLE RELAXANTS, ANTICARCINOGENIC AGENTS AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1996-03-12 US disclosed
EP-0318060-B1 Griseolic acid derivatives, their preparation and their use SANKYO CO (JP) 1995-10-25 EP disclosed
EP-0319050-B1 Griseolic acid derivatives, their preparation and their use SANKYO CO (JP) 1995-04-12 EP disclosed
EP-0251827-B1 NEW CYCLIC ETHER DERIVATIVES, THEIR PREPARATION AND THEIR USE Sankyo Company Limited (JP) 1993-09-15 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed
US-4891363-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY LIMITED (JP) 1990-01-02 US disclosed
EP-0214708-B1 GRISEOLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE SANKYO COMPANY LIMITED (JP) 1989-12-13 EP disclosed
EP-0319050-A2 Griseolic acid derivatives, their preparation and their use SANKYO COMPANY LIMITED (JP) 1989-06-07 EP disclosed
EP-0318060-A2 Griseolic acid derivatives, their preparation and their use Sankyo Company Limited (JP) 1989-05-31 EP disclosed
EP-0251827-A2 New cyclic ether derivatives, their preparation and their use Sankyo Company Limited (JP) 1988-01-07 EP disclosed